Medical Devices Startups

Naviday Health builds a platform that captures real-world health data from consumer devices and wearables and integrates it into clinical decision-making. The company focuses on women's health, starting with menopause management and planning to expand to cardiovascular risk and chronic care.

3 investors

Neocis develops Yomi, a robotic surgical platform that assists clinicians during dental implant surgery with planning, surgical, and restorative software features. The system is used by dental and oral surgery practices to place implants without physical surgical guides.

3 investors

Nephrogen develops AI-powered AAV delivery vehicles for genetic medicines targeting kidney and pancreatic diseases. The company uses high-throughput in vivo screening to design tissue-specific viral vectors that are significantly more efficient and less immunogenic than existing alternatives.

3 investors

NephroPlus is India's largest dialysis service provider offering hemodialysis, home and mobile dialysis, and pharmacy and wellness services across India, Nepal, the Philippines, and Uzbekistan. The company operates 490 clinics using a scalable, asset-light model and serves over 33,000 patients annually.

3 investors

Neptune Medical is a medical device company developing GI endoscopy products based on its Dynamic Rigidization technology, including the FDA-cleared Pathfinder endoscope and the Triton robotic endoscopy system for colon navigation. It designs, manufactures, and commercializes minimally invasive devices used by hospitals and academic medical centers in the U.S.

3 investors

Neurava develops AI-powered wearable devices designed to monitor seizures and cardiorespiratory dysfunction in people with epilepsy, aiming to mitigate the risk of SUDEP (Sudden Unexpected Nocturnal Death in Epilepsy). The company combines neuromodulation expertise with machine learning to create a novel medical device platform for epilepsy management.

3 investors

neuroClues develops a portable, CE-marked Class IIa eye-tracking device that records eye movements at high frame rates and uses AI algorithms to compute objective biomarkers, helping neurologists with differential diagnosis of parkinsonian syndromes and cerebellar assessment. The platform is aimed at clinical practice in hospitals and neurology clinics across Europe.

3 investors

NeuroPace is a commercial-stage medical device company that develops the RNS System, a brain-responsive neurostimulation platform delivering real-time treatment at the seizure source for patients with drug-resistant epilepsy and other brain disorders.

3 investors

Neurosoft Bio develops soft, elastic brain-computer interfaces that reduce mechanical mismatch with neural tissue for safer, longer-term implantation, and applies AI to analyze brain recordings for biomarker detection, neuromodulation, and decoding of motor and speech intentions. Its medical devices target patients with neurological disorders.

3 investors

Neurotrack provides remote cognitive assessment tools for clinicians to detect early cognitive decline through eye-tracking technology, enabling earlier intervention for patients at risk of Alzheimer's and cognitive conditions. The company serves health systems, health plans, and clinical providers seeking to screen for mild cognitive impairment before symptom progression.

3 investors

Nimbus acquires and consolidates pulmonary care practices across the United States, unifying them under standardized clinical protocols and connecting patients to care through its own technology platform. The company serves patients with chronic respiratory conditions including COPD, fibrotic interstitial lung disease, sleep apnea, and asthma.

3 investors

Niramai develops an AI-based, radiation-free thermal imaging medical device (Thermalytix, SMILE-100, and Mythri) for early detection of breast cancer, offering a low-cost, portable, non-invasive screening tool for use in clinics, hospitals, and outreach camps. The technology serves healthcare providers screening women across a wide age range and is deployed in over 22 countries.

3 investors

Norbert Health develops an autonomous, contactless health-monitoring system that captures vitals such as pulse and respiratory rate, conducts guided patient check-ins and cognitive, behavioral, and gait assessments, and writes clinical notes. Aimed at care facilities and clinical staff, the device rounds room to room, integrates with EMR and care management systems, and uses multimodal AI fusing vision, voice, and sensor data (currently for investigational and research use pending FDA clearance).

3 investors

Novadip develops a new class of regenerative tissue products aimed at accelerating the healing of large bone defects, bone non-union, and spine fusion in a single treatment. The company focuses on bone and tissue regenerative medicine for patients with critical bone defects, trauma, spinal conditions, and the rare congenital condition Congenital Pseudarthrosis of Tibia (CPT).

3 investors

NovaScan develops MarginScan, a compact device combining spectral bioimpedance and AI/ML to detect and localize cancer at the margins of surgical excisions in seconds, for use by surgeons in cancer procedures. The medical device technology, based on the Cole relaxation frequency, targets real-time surgical margin assessment for cancers including skin and breast, and is not yet FDA cleared.

3 investors

Novel Microdevices develops a portable, battery-powered point-of-care molecular diagnostic system that runs PCR-based nucleic acid amplification on disposable cartridges to detect pathogens and antibiotic-resistance mutations in about 15 minutes. The system targets same-visit testing and diagnosis, with an emphasis on low-resource settings and low- and middle-income countries.

3 investors

NOWDiagnostics develops rapid, point-of-care and consumer diagnostic tests. The company operates in the medical diagnostics and MedTech industry.

3 investors

Nucleix develops liquid biopsy and molecular diagnostic tests for early cancer detection, including its Bladder EpiCheck test for bladder and upper tract urinary cancer and a blood test in development for early-stage lung cancer. Its products are used by medical centers, laboratories, and healthcare systems, with offerings CE-marked in Europe and FDA 510(k) cleared in the United States.

3 investors

Numen develops at-home cancer diagnostics and health data collection infrastructure using machine learning models to enable earlier intervention and improve patient outcomes.

3 investors

Nutromics is developing a wearable patch for continuous, real-time monitoring of biomarkers in hospital settings, starting with therapeutic drug monitoring of the antibiotic vancomycin. The technology aims to help clinicians keep patients within the therapeutic range and is intended to expand into infectious disease, cardiology, and renal indications.

3 investors

Nuubo offers a wireless, non-invasive cardiac monitoring technology (aECG) based on textile electrodes for medium- and long-term remote heart monitoring. It serves healthcare professionals and patients in the cardiology monitoring field.

3 investors

Nuwellis is a commercial-stage medical device company that makes the Aquadex SmartFlow ultrafiltration system for cardiorenal fluid management. Its technology is used by clinicians to treat fluid overload in cardiac, ICU, pediatric, and kidney-failure patients, including cases of heart failure and acute kidney injury.

3 investors

Nyra Medical develops the CARLEN (Cardiac Leaflet Enhancer) system, a transcatheter single-leaflet device for repairing functional mitral regurgitation while preserving native valve function. It targets both TEER-suitable patients and those with limited existing treatment options in the cardiology/medical device field.

3 investors

NZeno develops porcine (pig) cell-based therapeutics and xenotransplantation technologies, building on work in encapsulated cell therapies and breeding pigs certified as tissue sources for human transplantation. The company operates in the biotechnology and regenerative medicine field.

3 investors